Press releases

Cancer: Quantum Surgical organizes its first European symposium at ECIO 2024 conference

Published on
April 22, 2024
Press Contact

Montpellier, April 22nd, 2024 – Quantum Surgical will attend the European Conference on Interventional Oncology (ECIO) held in Mallorca from April 28th to May 1st, dedicated to top interventional oncology KOLs. Quantum Surgical will present itsEpione® robotic ablation platform and organize its first European symposium, during which three key users will share their robotic experience: Pr. Thierry de Baere (Gustave Roussy, France), Pr. Laurent Milot (Hospices Civils de Lyon, France) and Dr. Gilles Piana (Institut Paoli-Calmettes, France).  

French medical robotics company Quantum Surgical will take part in the ECIO, which brings together top interventional oncology KOLs and experts on minimally invasive cancer care for knowledge exchange in the field.

Quantum Surgical will thus present its Epione® robotic platform dedicated to the early and curative treatment of tumors during the event held in Mallorca April 28 – May 1st and will host its first European symposium on “Epione®: How Robotics is Creating the Next Generation of IO Programs”.

During the symposium, users of Epione®, Pr. Thierry de Baere (Gustave Roussy, France), Pr. Laurent Milot (Hospices Civils de Lyon, France) and Dr. Gilles Piana (Institut Paoli-Calmettes, France) will share how robotics hasc hanged their way to perform and to teach percutaneous ablation procedures, as well as how they have been able to implement a robotics program in their institutions.

The symposium will be organized on Sunday, April 28, 18:30 – 18:55,Auditorium 2.

Epione® is a robot-assisted technology that allows physicians to perform safe and effective percutaneous tumor ablations, a minimally invasive treatment in which one or several needles are inserted through the skin to the tumor todestroy it.

Epione® is CE marked in Europe for abdomen and lung tumors, and FDA cleared for abdominal tumors. Hundreds of patients have already been treated worldwide.

The future of minimally invasive cancer treatment is today.